Biotest AG Stock price Xetra

Equities

BIO

DE0005227201

Pharmaceuticals

Market Closed - Xetra 12:36:22 2024-03-28 pm EDT After market 04:58:00 pm
42.4 EUR -0.93% Intraday chart for Biotest AG 42.2 -0.47%
Sales 2023 * 568M 612M Sales 2024 * 636M 686M Capitalization 1.37B 1.48B
Net income 2023 * -74M -79.82M Net income 2024 * -4M -4.31M EV / Sales 2023 * 3.49 x
Net Debt 2023 * 615M 663M Net Debt 2024 * 661M 713M EV / Sales 2024 * 3.19 x
P/E ratio 2023 *
-14.4 x
P/E ratio 2024 *
-265 x
Employees 2,228
Yield 2023 *
0.07%
Yield 2024 *
0.07%
Free-Float 29.83%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.64%
1 week-0.47%
Current month+0.47%
1 month+0.47%
3 months-0.47%
6 months-0.93%
Current year-0.47%
More quotes
1 week
42.40
Extreme 42.4
43.00
1 month
41.60
Extreme 41.6
43.00
Current year
40.40
Extreme 40.4
43.00
1 year
39.60
Extreme 39.6
44.00
3 years
27.60
Extreme 27.6
44.60
5 years
17.20
Extreme 17.2
44.60
10 years
11.70
Extreme 11.7
44.60
More quotes
Date Price Change Volume
24-03-28 42.4 -0.93% 0
24-03-27 42.8 +0.47% 10
24-03-26 42.6 0.00% 10
24-03-25 42.6 0.00% 10
24-03-22 42.6 0.00% 182

Delayed Quote Xetra, March 28, 2024 at 12:36 pm EDT

More quotes
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
26.8 EUR
Average target price
37 EUR
Spread / Average Target
+38.06%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Biotest AG
  4. Stock Biotest AG - Xetra